{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:58:16Z","timestamp":1760237896729,"version":"build-2065373602"},"reference-count":90,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1K23DK122199"],"award-info":[{"award-number":["1K23DK122199"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","award":["1K23GM128221-01A3","P30DK111024-05S1"],"award-info":[{"award-number":["1K23GM128221-01A3","P30DK111024-05S1"]}],"id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ecl.2021.05.009","type":"journal-article","created":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T06:40:32Z","timestamp":1628836832000},"page":"457-474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Advances in Pharmacotherapeutics, Metabolic Surgery, and Technology for Diabetes"],"prefix":"10.1016","volume":"50","author":[{"given":"Alfredo Daniel","family":"Guerr\u00f3n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia M.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco J.","family":"Pasquel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ecl.2021.05.009_bib1","doi-asserted-by":"crossref","first-page":"E886","DOI":"10.1152\/ajpendo.00608.2020","article-title":"The promising future of insulin therapy in diabetes mellitus","volume":"320","author":"Cheng","year":"2021","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"22","key":"10.1016\/j.ecl.2021.05.009_bib2","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1056\/NEJMoa2022474","article-title":"Once-weekly insulin for type 2 diabetes without previous insulin treatment","volume":"383","author":"Rosenstock","year":"2020","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ecl.2021.05.009_bib3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1203858","article-title":"Basal insulin and cardiovascular and other outcomes in dysglycemia","volume":"367","author":"Investigators","year":"2012","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.ecl.2021.05.009_bib4","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1056\/NEJMoa1615692","article-title":"Efficacy and safety of degludec versus glargine in type 2 diabetes","volume":"377","author":"Marso","year":"2017","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ecl.2021.05.009_bib5","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41551-019-0508-y","article-title":"Glucose-responsive insulin patch for the regulation of blood glucose in mice and minipigs","volume":"4","author":"Yu","year":"2020","journal-title":"Nat Biomed Eng"},{"issue":"3","key":"10.1016\/j.ecl.2021.05.009_bib6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/MAJ.0b013e3182a562b7","article-title":"Metformin-associated lactic acidosis","volume":"349","author":"Pasquel","year":"2015","journal-title":"Am J Med Sci"},{"issue":"9131","key":"10.1016\/j.ecl.2021.05.009_bib7","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","year":"1998","journal-title":"Lancet"},{"issue":"9131","key":"10.1016\/j.ecl.2021.05.009_bib8","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0140-6736(98)22937-0","article-title":"Some answers, more controversy, from UKPDS. United Kingdom prospective diabetes study","volume":"352","author":"Nathan","year":"1998","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ecl.2021.05.009_bib9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S2213-8587(20)30343-0","article-title":"Guideline recommendations and the positioning of newer drugs in type 2 diabetes care","volume":"9","author":"Marx","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"10.1016\/j.ecl.2021.05.009_bib10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur Heart J"},{"issue":"24","key":"10.1016\/j.ecl.2021.05.009_bib11","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa072761","article-title":"Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes","volume":"356","author":"Nissen","year":"2007","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.ecl.2021.05.009_bib12","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJMoa1506930","article-title":"Pioglitazone after ischemic stroke or transient ischemic attack","volume":"374","author":"Kernan","year":"2016","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.ecl.2021.05.009_bib13","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.ecl.2021.05.009_bib14","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJMoa1901118","article-title":"Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"381","author":"Husain","year":"2019","journal-title":"N Engl J Med"},{"issue":"10193","key":"10.1016\/j.ecl.2021.05.009_bib15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.ecl.2021.05.009_bib16","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJMoa1612917","article-title":"Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes","volume":"377","author":"Holman","year":"2017","journal-title":"N Engl J Med"},{"issue":"10157","key":"10.1016\/j.ecl.2021.05.009_bib17","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(18)32261-X","article-title":"Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial","volume":"392","author":"Hernandez","year":"2018","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ecl.2021.05.009_bib18","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.ecl.2021.05.009_bib19","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ecl.2021.05.009_bib20","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ecl.2021.05.009_bib21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/CIRCULATIONAHA.117.029190","volume":"136","author":"Kosiborod","year":"2017","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.ecl.2021.05.009_bib22","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.ecl.2021.05.009_bib23","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.ecl.2021.05.009_bib24","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.ecl.2021.05.009_bib25","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.ecl.2021.05.009_bib26","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa060326","article-title":"A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis","volume":"355","author":"Belfort","year":"2006","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ecl.2021.05.009_bib27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.7326\/M15-1774","article-title":"Long-term pioglitazone treatment for patients with nonalcoholic steatohepatitis and prediabetes or type 2 diabetes mellitus: a randomized trial","volume":"165","author":"Cusi","year":"2016","journal-title":"Ann Intern Med"},{"author":"Lilly News release","key":"10.1016\/j.ecl.2021.05.009_bib28"},{"issue":"10160","key":"10.1016\/j.ecl.2021.05.009_bib29","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/S0140-6736(18)32260-8","article-title":"Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial","volume":"392","author":"Frias","year":"2018","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ecl.2021.05.009_bib30","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1007\/s13300-020-00922-x","article-title":"Pharmacogenomic studies of current antidiabetic agents and potential new drug targets for precision medicine of diabetes","volume":"11","author":"Zeng","year":"2020","journal-title":"Diabetes Ther"},{"issue":"2","key":"10.1016\/j.ecl.2021.05.009_bib31","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2337\/dc17-2654","article-title":"Metabolic (bariatric and nonbariatric) surgery for type 2 diabetes: a personal perspective review","volume":"42","author":"Buchwald","year":"2019","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.ecl.2021.05.009_bib32","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1053\/j.gastro.2017.01.051","article-title":"Metabolic and bariatric surgery for obesity","volume":"152","author":"Vidal","year":"2017","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.ecl.2021.05.009_bib33","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.2337\/dci20-0006","article-title":"Success (but unfinished) story of metabolic surgery","volume":"43","author":"Aminian","year":"2020","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.ecl.2021.05.009_bib34","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.suc.2016.03.009","article-title":"Patient selection and surgical management of high-risk patients with morbid obesity","volume":"96","author":"Daniel Guerron","year":"2016","journal-title":"Surg Clin North Am"},{"issue":"6","key":"10.1016\/j.ecl.2021.05.009_bib35","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1007\/s00464-018-6500-x","article-title":"Asthma medication usage is significantly reduced following bariatric surgery","volume":"33","author":"Guerron","year":"2019","journal-title":"Surg Endosc"},{"issue":"10","key":"10.1016\/j.ecl.2021.05.009_bib36","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1007\/s11695-015-1657-z","article-title":"Bariatric surgery worldwide 2013","volume":"25","author":"Angrisani","year":"2015","journal-title":"Obes Surg"},{"author":"ASMBS","key":"10.1016\/j.ecl.2021.05.009_bib37"},{"author":"ASMBS","key":"10.1016\/j.ecl.2021.05.009_bib38"},{"key":"10.1016\/j.ecl.2021.05.009_bib39","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ijsu.2019.11.013","article-title":"Comparative analysis for the effect of Roux-en-Y gastric bypass vs sleeve gastrectomy in patients with morbid obesity: evidence from 11 randomized clinical trials (meta-analysis)","volume":"72","author":"Zhao","year":"2019","journal-title":"Int J Surg"},{"issue":"1","key":"10.1016\/j.ecl.2021.05.009_bib40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11695-014-1385-9","article-title":"Laparoscopic sleeve gastrectomy versus laparoscopic Roux-en-Y gastric bypass for morbid obesity and related comorbidities: a meta-analysis of 21 studies","volume":"25","author":"Zhang","year":"2015","journal-title":"Obes Surg"},{"issue":"3","key":"10.1016\/j.ecl.2021.05.009_bib41","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2174\/1573399810666140616144141","article-title":"Bariatric surgery - effects on obesity and related co-morbidities","volume":"10","author":"Svane","year":"2014","journal-title":"Curr Diabetes Rev"},{"issue":"2 Suppl","key":"10.1016\/j.ecl.2021.05.009_bib42","first-page":"487S","article-title":"Gastrointestinal surgery for severe obesity. Proceedings of a National Institutes of Health Consensus Development Conference. March 25-27, 1991, Bethesda, MD","volume":"55","year":"1992","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"10.1016\/j.ecl.2021.05.009_bib43","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2337\/dc16-0236","article-title":"Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations","volume":"39","author":"Rubino","year":"2016","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.ecl.2021.05.009_bib44","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/MOL.0000000000000696","article-title":"Metabolic and cardiovascular outcomes of bariatric surgery","volume":"31","author":"Iqbal","year":"2020","journal-title":"Curr Opin Lipidol"},{"issue":"7","key":"10.1016\/j.ecl.2021.05.009_bib45","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1056\/NEJMoa1600869","article-title":"Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes","volume":"376","author":"Schauer","year":"2017","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ecl.2021.05.009_bib46","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00125-016-3903-x","article-title":"Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial","volume":"59","author":"Cummings","year":"2016","journal-title":"Diabetologia"},{"issue":"10271","key":"10.1016\/j.ecl.2021.05.009_bib47","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(20)32649-0","article-title":"Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial","volume":"397","author":"Mingrone","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ecl.2021.05.009_bib48","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S2213-8587(13)70070-6","article-title":"Preoperative prediction of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a retrospective cohort study","volume":"2","author":"Still","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"10.1016\/j.ecl.2021.05.009_bib49","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.soard.2018.12.020","article-title":"DiaRem2: incorporating duration of diabetes to improve prediction of diabetes remission after metabolic surgery","volume":"15","author":"Still","year":"2019","journal-title":"Surg Obes Relat Dis"},{"issue":"3","key":"10.1016\/j.ecl.2021.05.009_bib50","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.soard.2012.07.015","article-title":"Predicting success of metabolic surgery: age, body mass index, C-peptide, and duration score","volume":"9","author":"Lee","year":"2013","journal-title":"Surg Obes Relat Dis"},{"issue":"4","key":"10.1016\/j.ecl.2021.05.009_bib51","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/SLA.0000000000002407","article-title":"Individualized metabolic surgery score: procedure selection based on diabetes severity","volume":"266","author":"Aminian","year":"2017","journal-title":"Ann Surg"},{"issue":"10","key":"10.1016\/j.ecl.2021.05.009_bib52","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.soard.2020.05.010","article-title":"Performance and improvement of the DiaRem score in diabetes remission prediction: a study with diverse procedure types","volume":"16","author":"Guerron","year":"2020","journal-title":"Surg Obes Relat Dis"},{"issue":"11","key":"10.1016\/j.ecl.2021.05.009_bib53","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1089\/dia.2014.0378","article-title":"The performance and usability of a factory-calibrated flash glucose monitoring system","volume":"17","author":"Bailey","year":"2015","journal-title":"Diabetes Technol Ther"},{"issue":"6","key":"10.1016\/j.ecl.2021.05.009_bib54","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1089\/dia.2018.0143","article-title":"Performance of a factory-calibrated real-time continuous glucose monitoring system utilizing an automated sensor applicator","volume":"20","author":"Shah","year":"2018","journal-title":"Diabetes Technol Ther"},{"issue":"6","key":"10.1016\/j.ecl.2021.05.009_bib55","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/dia.2018.0150","article-title":"Accuracy of a factory-calibrated, real-time continuous glucose monitoring system during 10 days of use in youth and adults with diabetes","volume":"20","author":"Wadwa","year":"2018","journal-title":"Diabetes Technol Ther"},{"issue":"5","key":"10.1016\/j.ecl.2021.05.009_bib56","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.2337\/dc19-1459","article-title":"Effects of continuous glucose monitoring on metrics of glycemic control in diabetes: a systematic review with meta-analysis of randomized controlled trials","volume":"43","author":"Maiorino","year":"2020","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.ecl.2021.05.009_bib57","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s13300-020-00831-z","article-title":"Evolution of insulin delivery devices: from syringes, pens, and pumps to DIY artificial pancreas","volume":"11","author":"Kesavadev","year":"2020","journal-title":"Diabetes Ther"},{"issue":"15","key":"10.1016\/j.ecl.2021.05.009_bib58","first-page":"1474","article-title":"Threshold insulin-pump interruption to reduce hypoglycemia","volume":"369","author":"Bergenstal","year":"2013","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ecl.2021.05.009_bib59","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1089\/dia.2018.0199","article-title":"Impact of sensor-augmented pump therapy with predictive low-glucose suspend function on glycemic control and patient satisfaction in adults and children with type 1 diabetes","volume":"20","author":"Beato-Vibora","year":"2018","journal-title":"Diabetes Technol Ther"},{"issue":"10","key":"10.1016\/j.ecl.2021.05.009_bib60","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.2337\/dc18-0771","article-title":"Predictive low-glucose suspend reduces hypoglycemia in adults, adolescents, and children with type 1 diabetes in an at-home randomized crossover study: results of the PROLOG trial","volume":"41","author":"Forlenza","year":"2018","journal-title":"Diabetes Care"},{"author":"Medtronic press release","key":"10.1016\/j.ecl.2021.05.009_bib61"},{"issue":"8","key":"10.1016\/j.ecl.2021.05.009_bib62","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.2337\/dc19-1785","article-title":"Time in range for multiple technologies in type 1 diabetes: a systematic review and network meta-analysis","volume":"43","author":"Pease","year":"2020","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.ecl.2021.05.009_bib63","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s13300-020-00823-z","article-title":"The do-it-yourself artificial pancreas: a comprehensive review","volume":"11","author":"Kesavadev","year":"2020","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.ecl.2021.05.009_bib64","doi-asserted-by":"crossref","DOI":"10.1177\/1932296820923045","article-title":"Individualizing inpatient diabetes management during the coronavirus disease 2019 pandemic","author":"Pasquel","year":"2020","journal-title":"J Diabetes Sci Technol"},{"issue":"10","key":"10.1016\/j.ecl.2021.05.009_bib65","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.2337\/dc20-1503","article-title":"Feasibility of inpatient continuous glucose monitoring during the COVID-19 pandemic: early experience","volume":"43","author":"Reutrakul","year":"2020","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.ecl.2021.05.009_bib66","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.2337\/dc20-0696","article-title":"Remote glucose monitoring of hospitalized, quarantined patients with diabetes and COVID-19","volume":"43","author":"Shehav-Zaltzman","year":"2020","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.ecl.2021.05.009_bib67","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1089\/dia.2020.0237","article-title":"Usefulness and safety of remote continuous glucose monitoring for a severe COVID-19 patient with diabetes","volume":"23","author":"Ushigome","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"10.1016\/j.ecl.2021.05.009_bib68","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2337\/dc20-2219","article-title":"Continuous glucose monitoring in the intensive care unit during the COVID-19 pandemic","volume":"44","author":"Agarwal","year":"2021","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.ecl.2021.05.009_bib69","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2337\/dc20-2085","article-title":"Remote continuous glucose monitoring with a computerized insulin infusion protocol for critically ill patients in a COVID-19 medical ICU: proof of concept","volume":"44","author":"Davis","year":"2021","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.ecl.2021.05.009_bib70","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1089\/dia.2020.0206","article-title":"Inpatient transition to virtual care during COVID-19 pandemic","volume":"22","author":"Jones","year":"2020","journal-title":"Diabetes Technol Ther"},{"author":"Dexcom press release","key":"10.1016\/j.ecl.2021.05.009_bib71"},{"key":"10.1016\/j.ecl.2021.05.009_bib73","doi-asserted-by":"crossref","DOI":"10.1177\/1932296820932903","article-title":"Implementation of continuous glucose monitoring in the hospital: emergent considerations for remote glucose monitoring during the COVID-19 pandemic","author":"Galindo","year":"2020","journal-title":"J Diabetes Sci Technol"},{"issue":"3","key":"10.1016\/j.ecl.2021.05.009_bib74","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S2213-8587(20)30381-8","article-title":"Management of diabetes and hyperglycaemia in the hospital","volume":"9","author":"Pasquel","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"10.1016\/j.ecl.2021.05.009_bib75","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.2337\/dc20-0944","article-title":"Early observation and mitigation of challenges in diabetes management of COVID-19 patients in critical care units","volume":"43","author":"Hamdy","year":"2020","journal-title":"Diabetes Care"},{"issue":"7258","key":"10.1016\/j.ecl.2021.05.009_bib76","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ"},{"issue":"14","key":"10.1016\/j.ecl.2021.05.009_bib77","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ecl.2021.05.009_bib78","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2337\/dc17-1600","article-title":"International consensus on use of continuous glucose monitoring","volume":"40","author":"Danne","year":"2017","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.ecl.2021.05.009_bib79","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.ecl.2021.05.009_bib80","doi-asserted-by":"crossref","first-page":"400","DOI":"10.2337\/dc18-1444","article-title":"Validation of time in range as an outcome measure for diabetes clinical trials","volume":"42","author":"Beck","year":"2019","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.ecl.2021.05.009_bib81","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1001\/jamainternmed.2020.7484","article-title":"Comparing health outcomes of privileged US citizens with those of average residents of other developed countries","volume":"181","author":"Emanuel","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"10","key":"10.1016\/j.ecl.2021.05.009_bib82","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S2213-8587(19)30260-8","article-title":"Unaffordable insulin: patients pay the price","volume":"7","author":"Conner","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.ecl.2021.05.009_bib83","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-016-0670-y","article-title":"Empowered citizen \u2018health hackers\u2019 who are not waiting","volume":"14","author":"Omer","year":"2016","journal-title":"BMC Med"},{"issue":"2","key":"10.1016\/j.ecl.2021.05.009_bib84","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/1932296818795705","article-title":"Twitter analysis of #OpenAPS DIY artificial pancreas technology use suggests improved A1C and quality of life","volume":"13","author":"Litchman","year":"2019","journal-title":"J Diabetes Sci Technol"},{"issue":"6","key":"10.1016\/j.ecl.2021.05.009_bib85","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.2337\/dci18-0010","article-title":"Need for regulatory change to incorporate beyond A1C glycemic metrics","volume":"41","year":"2018","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.ecl.2021.05.009_bib86","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.soard.2019.02.001","article-title":"Long-term outcomes of laparoscopic sleeve gastrectomy versus Roux-en-Y gastric bypass for morbid obesity: results from a meta-analysis of randomized controlled trials","volume":"15","author":"Yang","year":"2019","journal-title":"Surg Obes Relat Dis"},{"issue":"8","key":"10.1016\/j.ecl.2021.05.009_bib87","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s12325-017-0562-3","article-title":"Intragastric balloon treatment for obesity: review of recent studies","volume":"34","author":"Tate","year":"2017","journal-title":"Adv Ther"},{"issue":"6","key":"10.1016\/j.ecl.2021.05.009_bib88","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1089\/lap.2020.0155","article-title":"This is how we do it: laparoscopic Roux-en-Y gastric bypass","volume":"30","author":"Landin","year":"2020","journal-title":"J Laparoendosc Adv Surg Tech A"},{"issue":"4","key":"10.1016\/j.ecl.2021.05.009_bib89","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4103\/0972-9941.181352","article-title":"Current status of mini-gastric bypass","volume":"12","author":"Mahawar","year":"2016","journal-title":"J Minim Access Surg"},{"issue":"5","key":"10.1016\/j.ecl.2021.05.009_bib90","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1007\/s11695-018-3182-3","article-title":"Mini gastric bypass-one anastomosis gastric bypass (MGB-OAGB)-IFSO position statement","volume":"28","author":"De Luca","year":"2018","journal-title":"Obes Surg"},{"year":"2020","series-title":"Biliopancreatic diversion with duodenal switch","author":"Conner","key":"10.1016\/j.ecl.2021.05.009_bib91"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852921000438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852921000438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:47:12Z","timestamp":1760176032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852921000438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0889852921000438"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2021.05.009","relation":{},"ISSN":["0889-8529"],"issn-type":[{"type":"print","value":"0889-8529"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in Pharmacotherapeutics, Metabolic Surgery, and Technology for Diabetes","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2021.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}